Member Info for BBB11

That's right he is at:

https://www.longwoodhealthcareleaders.com/bostonceo

NotPosting... That was 2020. You're showing incredible bias and zero value. He provides excellent company overviews, expected updates, and combats misinformation.

All you seem to do is spread it

Next RNS to expect:

ASH Late-Breaking Abstract (LBA)

Likely Date: Submission by 29 Oct

What We Want: Confirmation HEMO has submitted an LBA to ASH, with acceptance news expected mid–to–late Nov.

2️⃣ HG-CT-1 CAR-T Clinical Update

Likely Date: November

What We Want: “First paediatric patient dosed” or “next cohort progressing safely. which shows real clinical momentum in the AML CAR-T trial.

3️⃣ Manufacturing / CMC Milestone

Likely Date: November or early Dec

What We Want: RNS confirmation of tech transfer completion or first GMP batch readiness with Made Scientific.

4️⃣ Estonia Hospital-Exemption LOI

Likely Date: Next week / by mid-November

What We Want: Progress from LOI to a binding agreement or the first implementation step, which opens a route to early commercialisation in the EU.

Someone is buying good sums now... Watch this go right back up before close!

Honestly pretty shocked it's going down so much.

News does need to come next week.

I agree with MrIndia. I've been here nearly 6 years. I just bought £2500 worth as a little top up as the SP is ridiculously low.

We are all waiting for the RNS news, and a few of them in a short time frame should see a very nice jump.

The traders push it down, then pump it when news comes out. That's why it went up 12x etc.

I wouldn't be surprised if one drops tomorrow, but definitely one by 1st of November.

I went on to check and I can still sell shares if I wanted. I assume low buying activity? Anyone have anything else that's a credible reason?

Https://www.reddit.com/r/Hemogenyx/s/JDGiYBn6oG

Anyone on the HEMO Reddit thread? Thinking we should ignite this... Thoughts? Be good to see peoples massive wins on Hemo.

Hemogenyx USPs:

Dual-target CD33/CD123 CAR-T – tackles AML relapse where others failed.

Paediatric clearance at MD Anderson – rare early-stage advantage.

Manufacturing secured with Made Scientific – scale and quality already in motion, again early.

CBR & CDX platforms – long-term pipeline beyond AML.

Competition:

Most rivals (Cellectis, Autolus, MSK) are single-target or still academic. None have cracked AML durability or safety like Hemo’s early data suggests.

What Vlad’s Learned:

Fixed the FDA hold fast, secured GMP production early, kept the science clean, learning from bigger peers’ mistakes.

Stand-Outs:

MRD-negative patient data already seen.

First EU commercial pathway (Estonia deal).

Micro-float, real progress, no noise.

Avoid:

Premature dilution, hype over data, spreading thin before partnership.

Next Positives / RNS to Watch:

Paediatric dosing start

Cohort 2 safety

Estonia first-use

Manufacturing milestone

Strategic hires / JV talk

Summary:

Science proven, execution improving, market still asleep. Get the next 2–3 RNS right and Hemo re-rates. This is shaping up as one of the London Stock Exchange few genuine biotech success stories in the making.

We all know the science is there, with dual-target CAR-T, clean safety, paediatric clearance, and a CDMO already onboard. The only real gap now is senior hires.

Add a dealmaker, a seasoned regulatory lead, and a strong CFO, and this becomes a serious biotech worthy of a £500m valuation.

Once those roles land, with data due in early 2026, this could re-rate to £500m fast. The hard part (the science) is done, so now it’s about execution.

Broch - yes

Alde it shows you shouldn't be invested in Hemo

Mickey, a company with a revenue pipeline already which can be expanded is still far more attractive. If you see there is demand from a country like Estonia with people flying in for treatment, then imagine being a big pharma with the facilities across UK, Italy, Germany, France... let alone the USA and Canada etc.

I think it's a stronger case to be bought then not, showing demand for a product is a strong buy signal IMO

JHFH - How would you be ramping? Surely it's a typical process, they either buy via a hostile share buy on open market, get a TR1 and make an offer, or approach the company directly, either way it goes to a vote given my understanding...

However given the amount of your shareholding, and a few other LTH... You have a significant influence on how people vote.

Genuinely interested in the process, and also if you would say yay or nay at say £250m / £500m etc.

JHFH... I have a question.

Given Vlad and his wife own less then 5% of the company, how would an offer of the company be considered? Would we need the classic 75% agreement from shareholders?

I see this becoming more and more likely next year. What do you anticipate the process is here, for how an offer would be considered?

Boom you obviously have an agenda.

Seller is back however for a few more sells it seems. Hopefully our buyer and seller isn't the same person manipulating the price

Now we have someone buying 10k blocks! Wowza

If this seller has stopped, or holds off for just an hour, this will rally

This is either a warrant holder, or a very large retail trader as they're being dumped on the live market.

I've had to sell some at this point to manage risk. It's ridiculous.

Trump's tariff won't even affect Hemo as manufacturing is done in the USA FFS.

Stop losses have been taken out.